Nephrology
Conference Coverage
‘Stunning’ twincretin beats semaglutide for A1c, weight reduction in T2D
Head-to-head pivotal trial results show weekly tirzepatide injections surpassed 1 mg semaglutide weekly for A1c reduction and weight loss.
Livin' on the MDedge
The most important meal of the day, with extra zinc
Plus, livers live the hop life and babies get scared by their microbiomes.
From the Journals
Third COVID-19 vaccine dose helped some transplant recipients
All of those with low titers before the third dose had high titers after receiving the extra shot, in case series.
Livin' on the MDedge
Gene therapy is bad business, and hugging chickens is just … bad
Plus, brains that can type and geologists who conduct kidney research.
Applied Evidence
A guide to diagnosing and managing ascites in cirrhosis
Combined serum and ascites fluid measurements point to the cause of ascites. For patients with modest edema, a reduced weight-loss target with...
Latest News
Infants with UTI do not have an increased risk of bacterial meningitis
Febrile infants with positive urinalysis results do not have a higher risk of bacterial meningitis than those with negative urinalysis results,...
Conference Coverage
Ultrasound renal denervation drops BP in patients on triple therapy
Practice Alert
A review of the latest USPSTF recommendations
The Task Force has expanded the age range for screening for hepatitis C virus infection in adolescents and adults, and now endorses behavioral...
Conference Coverage
Keep antibiotics unchanged in breakthrough UTIs
Risk of a second resistant urinary tract infection was not increased by changing continuous antibiotics in children.
Feature
Finerenone scores second pivotal-trial success in patients with diabetic kidney disease
News
FDA approves dapagliflozin (Farxiga) for chronic kidney disease
Based on results of the DAPA-CKD trial, the FDA has granted approval for the diabetes drug in patients with CKD at risk for disease progression....